INDIAN SCIENTISTS INCH CLOSER TO DEVELOP A NEW BLOOD CANCER DRUG
DR REDDY’ S LABORATORIES GETS USFDA’ S EIR TO API PLANT IN TELANGANA
news bytes
INDIAN SCIENTISTS INCH CLOSER TO DEVELOP A NEW BLOOD CANCER DRUG
A group of Indian scientists has a found a new compound that effectively kills leukemic cancer cells. Codenamed 5g, the new drug can kill over 70 percent blood cancer cells in a petri dish in 48 hours at an extremely low concentration. It did not affect healthy blood cells, which signifies that is toxic to cancer cells.“ After treating with 5g cancer cells either entered cell death or reverted back to normal cell cycle”, say scientists who have tested this new compound.
The drug has been tested in laboratory animals. Daily doses of 5g for two weeks reduced the size of tumor in mice. It was non-toxic and moderately increased the life span of diseased mice. The tumor regression was incomplete, because of which, the scientists suggest that 5g needs combinational compounds to increase its efficiency.
This study was done at the Indian
Institute of Science in Bangalore, University of Mysore in Mysuru, and Institute of Bioinformatics and Applied Biotechnology in Bangalore. It was supported by IISc-Department of Biotechnology partnership.
DR REDDY’ S LABORATORIES GETS USFDA’ S EIR TO API PLANT IN TELANGANA
Dr Reddy’ s Laboratories in its recent filing to the National Stock Exchange( NSE) broke the news that company has received an establishment inspection report( EIR) from the USFDA on 16th June as the closure of audit for the above-referred facility.
The company has said that the US Food and Drug Administration, which inspected active pharmaceutical ingredients( API) unit at Miryalaguda in Telangana in March this year, has given an‘ establishment inspection report’.
Earlier on February 21, the company had informed that the FDA had issued form 483 with
58 BioVoiceNews | July 2017